Japan Pharmaceutical Market Size & Outlook, 2024-2030
Japan pharmaceutical market, 2018-2030 (US$M)
Related Markets
Japan pharmaceutical market highlights
- The Japan pharmaceutical market generated a revenue of USD 71,513.1 million in 2024 and is expected to reach USD 103,054.1 million by 2030.
- The Japan market is expected to grow at a CAGR of 6.3% from 2025 to 2030.
- In terms of segment, conventional drugs (small molecules) was the largest revenue generating molecule in 2024.
- Biologics & Biosimilars (Large Molecules) is the most lucrative molecule segment registering the fastest growth during the forecast period.
Pharmaceutical market data book summary
| Market revenue in 2024 | USD 71,513.1 million |
| Market revenue in 2030 | USD 103,054.1 million |
| Growth rate | 6.3% (CAGR from 2025 to 2030) |
| Largest segment | Conventional drugs (small molecules) |
| Fastest growing segment | Biologics & Biosimilars (Large Molecules) |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules) |
| Key market players worldwide | Merck & Co Inc, Roche Holding AG, Novartis AG ADR, AbbVie Inc, Johnson & Johnson, Pfizer Inc, Bristol-Myers Squibb Co, Sanofi SA, GSK PLC, Takeda Pharmaceutical Co Ltd |
Other key industry trends
- In terms of revenue, Japan accounted for 4.3% of the global pharmaceutical market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China pharmaceutical market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 63,747.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Market Scope
Pharmaceutical Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan pharmaceutical market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical market will help companies and investors design strategic landscapes.
Conventional drugs (small molecules) was the largest segment with a revenue share of 57.67% in 2024. Horizon Databook has segmented the Japan pharmaceutical market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.
Japan remains a key player in the global pharmaceutical market, driven by its high per capita income and aging population. However, government policies, such as biennial price cuts on prescription drugs, have led to a decline in Japan’s global market share.
In 2021, the Japanese government revised the prices of 70% of drugs listed on the National Health Insurance (NHI) list, impacting pharmaceutical revenues. Additionally, Japan has faced challenges in drug discovery, evident in the delayed introduction of COVID-19 treatments compared to the U.S. and Europe.
To revitalize the sector, Japan’s Ministry of Health, Labour and Welfare (MHLW) introduced a Vision Plan for the pharmaceutical industry in September 2021. This plan focuses on increasing overseas sales, boosting R&D investment, expanding the number of top-selling drugs originating in Japan, and enhancing licensing activity within the domestic market.
Reasons to subscribe to Japan pharmaceutical market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan pharmaceutical market databook
-
Our clientele includes a mix of pharmaceutical market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan pharmaceutical market , including forecasts for subscribers. This country databook contains high-level insights into Japan pharmaceutical market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan pharmaceutical market size, by molecule, 2018-2030 (US$M)
Japan Pharmaceutical Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
No records
No related industry reports found.
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
